ASH News Daily 2017 - Issue 2 - C-30
ASH News Daily
Page C-30
Sunday, December 10, 2017
®
Sunday's Poster Sessions
Session ...................................................... Paper Ranges
100s
101. Red Cells and Erythropoiesis, Structure and Function,
Metabolism, and Survival, Excluding Iron: Poster II ................................... 2194 - 2210
102. Regulation of Iron Metabolism: Poster II .................................................... 2211 - 2218
112. Thalassemia and Globin Gene Regulation: Poster II .................................. 2219 - 2227
113. Hemoglobinopathies, Excluding Thalassemia-Basic and
Translational Science: Poster II .................................................................. 2228 - 2243
114. Hemoglobinopathies, Excluding Thalassemia-Clinical: Poster II.............. 2244 - 2264
200s
201. Granulocytes, Monocytes, and Macrophages: Poster II ............................. 2265 - 2278
203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency,
including HIV and Other Infections: Poster II.............................................. 2279 - 2294
300s
301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet
Adhesion, Activation, and Biochemistry: Poster II ...................................... 2295 - 2309
311. Disorders of Platelet Number or Function: Poster II ................................... 2310 - 2334
321. Blood Coagulation and Fibrinolytic Factors: Poster II................................. 2335 - 2350
322. Disorders of Coagulation or Fibrinolysis: Poster II ..................................... 2351 - 2373
331. Pathophysiology of Thrombosis: Poster II .................................................. 2374 - 2385
332. Antithrombotic Therapy: Poster II ............................................................... 2386 - 2397
400s
401. Basic Science and Clinical Practice in Blood Transfusion: Poster II .......... 2398 - 2412
500s
501. Hematopoietic Stem and Progenitor Biology: Poster II .............................. 2413 - 2427
502. Hematopoiesis: Regulation of Gene Transcription, Cytokines,
Signal Transduction, Apoptosis, and Cell Cycle Regulation: Poster II........ 2428 - 2436
506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion,
and Stromal Stem Cells: Poster II .............................................................. 2437 - 2445
508. Bone Marrow Failure: Poster II ................................................................... 2446 - 2468
600s
602. Disordered Gene Expression in Hematologic Malignancy, including
Disordered Epigenetic Regulation: Poster II............................................... 2469 - 2488
603. Oncogenes and Tumor Suppressors: Poster II .......................................... 2489 - 2516
604. Molecular Pharmacology and Drug Resistance in Myeloid
Diseases: Poster II ..................................................................................... 2517 - 2533
605. Molecular Pharmacology, Drug Resistance-Lymphoid and
Other Diseases: Poster II ........................................................................... 2534 - 2548
612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster II ........................ 2549 - 2576
613. Acute Myeloid Leukemia: Clinical Studies: Poster II................................... 2577 - 2596
614. Acute Lymphoblastic Leukemia: Therapy, excluding
Transplantation: Poster II............................................................................ 2597 - 2611
615. Acute Myeloid Leukemia: Commercially Available Therapy,
excluding Transplantation: Poster II ........................................................... 2612 - 2620
616. Acute Myeloid Leukemia: Novel Therapy, excluding
Transplantation: Poster II............................................................................ 2621 - 2662
617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular
Markers in Diagnosis and Prognosis: Poster II........................................... 2663 - 2707
618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and
Molecular Markers in Diagnosis and Prognosis: Poster II .......................... 2708 - 2727
621. Lymphoma-Genetic/Epigenetic Biology: Poster II .................................... 2728 - 2747
622. Lymphoma Biology-Non-Genetic Studies: Poster II ................................. 2748 - 2764
623. Mantle Cell, Follicular, and Other Indolent B-Cell
Lymphoma-Clinical Studies: Poster II ...................................................... 2765 - 2786
624. Hodgkin Lymphoma and T/NK Cell Lymphoma-Clinical Studies: Poster II .......2787 - 2806
625. Lymphoma: Pre-Clinical-Chemotherapy and Biologic Agents: Poster II .. 2807 - 2820
626. Aggressive Lymphoma (Diffuse Large B-Cell and Other
Aggressive B-Cell Non-Hodgkin Lymphomas)-Results
from Prospective Clinical Trials: Poster II ................................................... 2821 - 2835
627. Aggressive Lymphoma (Diffuse Large B-Cell and Other
Aggressive B-Cell Non-Hodgkin Lymphomas)-Results from
Retrospective/Observational Studies: Poster II .......................................... 2836 - 2859
631. Chronic Myeloid Leukemia: Biology and Pathophysiology,
excluding Therapy: Poster II ....................................................................... 2860 - 2867
632. Chronic Myeloid Leukemia: Therapy: Poster II........................................... 2868 - 2907
634. Myeloproliferative Syndromes: Clinical: Poster II ....................................... 2908 - 2930
635. Myeloproliferative Syndromes: Basic Science: Poster II ............................ 2931 - 2945
636. Myelodysplastic Syndromes-Basic and Translational Studies: Poster II ..... 2946 - 2962
637. Myelodysplastic Syndromes-Clinical Studies: Poster II ........................... 2963 - 2986
641. CLL: Biology and Pathophysiology, excluding Therapy: Poster II .............. 2987 - 3008
642. CLL: Therapy, excluding Transplantation: Poster II .................................... 3009 - 3026
651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster II ...... 3027 - 3066
652. Myeloma: Pathophysiology and Pre-Clinical Studies,
excluding Therapy: Poster II ....................................................................... 3067 - 3086
653. Myeloma: Therapy, excluding Transplantation: Poster II ............................ 3087 - 3164
700s
701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Poster II ....3165 - 3178
703. Adoptive Immunotherapy: Poster II ............................................................ 3179 - 3194
711. Cell Collection and Processing: Poster II.................................................... 3195 - 3203
721. Clinical Allogeneic Transplantation: Conditioning Regimens,
Engraftment, and Acute Transplant Toxicities: Poster II ............................. 3204 - 3243
722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD,
Immune Reconstitution: Poster II ............................................................... 3244 - 3265
723. Clinical Allogeneic and Autologous Transplantation: Late
Complications and Approaches to Disease Recurrence: Poster II ............. 3266 - 3281
731. Clinical Autologous Transplantation: Results: Poster II .............................. 3282 - 3300
732. Clinical Allogeneic Transplantation: Results: Poster II................................ 3301 - 3330
800s
801. Gene Therapy and Transfer: Poster II ........................................................ 3331 - 3342
802. Chemical Biology and Experimental Therapeutics: Poster II...................... 3343 - 3349
900s
901. Health Services Research-Non-Malignant Conditions: Poster II.............. 3350 - 3375
902. Health Services Research-Malignant Conditions: Poster II ..................... 3376 - 3405
903. Outcomes Research-Non-Malignant Conditions: Poster II ...................... 3406 - 3421
904. Outcomes Research-Malignant Conditions: Poster II .............................. 3422 - 3466
Posters will be available for
viewing in Hall A2 of the
Georgia World Congress Center
at the times listed below.
Meeting attendees will have the
opportunity to meet the
abstract authors to discuss their
research and ask questions
during the presentation times
listed. Attendees can also take
advantage of PosterCast, a new
feature that provides audio
narration of posters, recorded
directly by the author. Visit the
poster hall to learn more.
Sunday, December 10
Poster Session II - Viewing:
9:00 a.m. - 8:00 p.m.
Poster Session II - Presentations:
6:00 p.m. - 8:00 p.m.
Poster Hall Reception:
6:00 p.m. - 8:00 p.m.
Table of Contents for the Digital Edition of ASH News Daily 2017 - Issue 2
ASH News Daily 2017 - Issue 2 - A-1
ASH News Daily 2017 - Issue 2 - A-2
ASH News Daily 2017 - Issue 2 - A-3
ASH News Daily 2017 - Issue 2 - A-4
ASH News Daily 2017 - Issue 2 - A-5
ASH News Daily 2017 - Issue 2 - A-6
ASH News Daily 2017 - Issue 2 - A-7
ASH News Daily 2017 - Issue 2 - A-8
ASH News Daily 2017 - Issue 2 - A-9
ASH News Daily 2017 - Issue 2 - A-10
ASH News Daily 2017 - Issue 2 - A-11
ASH News Daily 2017 - Issue 2 - A-12
ASH News Daily 2017 - Issue 2 - A-13
ASH News Daily 2017 - Issue 2 - A-14
ASH News Daily 2017 - Issue 2 - A-15
ASH News Daily 2017 - Issue 2 - A-16
ASH News Daily 2017 - Issue 2 - A-17
ASH News Daily 2017 - Issue 2 - A-18
ASH News Daily 2017 - Issue 2 - A-19
ASH News Daily 2017 - Issue 2 - A-20
ASH News Daily 2017 - Issue 2 - A-21
ASH News Daily 2017 - Issue 2 - A-22
ASH News Daily 2017 - Issue 2 - A-23
ASH News Daily 2017 - Issue 2 - A-24
ASH News Daily 2017 - Issue 2 - A-25
ASH News Daily 2017 - Issue 2 - A-26
ASH News Daily 2017 - Issue 2 - A-27
ASH News Daily 2017 - Issue 2 - A-28
ASH News Daily 2017 - Issue 2 - B-1
ASH News Daily 2017 - Issue 2 - B-2
ASH News Daily 2017 - Issue 2 - B-3
ASH News Daily 2017 - Issue 2 - B-4
ASH News Daily 2017 - Issue 2 - B-5
ASH News Daily 2017 - Issue 2 - B-6
ASH News Daily 2017 - Issue 2 - B-7
ASH News Daily 2017 - Issue 2 - B-8
ASH News Daily 2017 - Issue 2 - B-9
ASH News Daily 2017 - Issue 2 - B-10
ASH News Daily 2017 - Issue 2 - B-11
ASH News Daily 2017 - Issue 2 - B-12
ASH News Daily 2017 - Issue 2 - B-13
ASH News Daily 2017 - Issue 2 - B-14
ASH News Daily 2017 - Issue 2 - B-15
ASH News Daily 2017 - Issue 2 - B-16
ASH News Daily 2017 - Issue 2 - B-17
ASH News Daily 2017 - Issue 2 - B-18
ASH News Daily 2017 - Issue 2 - B-19
ASH News Daily 2017 - Issue 2 - B-20
ASH News Daily 2017 - Issue 2 - B-21
ASH News Daily 2017 - Issue 2 - B-22
ASH News Daily 2017 - Issue 2 - B-23
ASH News Daily 2017 - Issue 2 - B-24
ASH News Daily 2017 - Issue 2 - B-25
ASH News Daily 2017 - Issue 2 - B-26
ASH News Daily 2017 - Issue 2 - B-27
ASH News Daily 2017 - Issue 2 - B-28
ASH News Daily 2017 - Issue 2 - B-29
ASH News Daily 2017 - Issue 2 - B-30
ASH News Daily 2017 - Issue 2 - B-31
ASH News Daily 2017 - Issue 2 - B-32
ASH News Daily 2017 - Issue 2 - B-33
ASH News Daily 2017 - Issue 2 - B-34
ASH News Daily 2017 - Issue 2 - B-35
ASH News Daily 2017 - Issue 2 - B-36
ASH News Daily 2017 - Issue 2 - B-37
ASH News Daily 2017 - Issue 2 - B-38
ASH News Daily 2017 - Issue 2 - B-39
ASH News Daily 2017 - Issue 2 - B-40
ASH News Daily 2017 - Issue 2 - B-41
ASH News Daily 2017 - Issue 2 - B-42
ASH News Daily 2017 - Issue 2 - B-43
ASH News Daily 2017 - Issue 2 - B-44
ASH News Daily 2017 - Issue 2 - B-45
ASH News Daily 2017 - Issue 2 - B-46
ASH News Daily 2017 - Issue 2 - B-47
ASH News Daily 2017 - Issue 2 - B-48
ASH News Daily 2017 - Issue 2 - B-49
ASH News Daily 2017 - Issue 2 - B-50
ASH News Daily 2017 - Issue 2 - B-51
ASH News Daily 2017 - Issue 2 - B-52
ASH News Daily 2017 - Issue 2 - B-53
ASH News Daily 2017 - Issue 2 - B-54
ASH News Daily 2017 - Issue 2 - B-55
ASH News Daily 2017 - Issue 2 - B-56
ASH News Daily 2017 - Issue 2 - C-1
ASH News Daily 2017 - Issue 2 - C-2
ASH News Daily 2017 - Issue 2 - C-3
ASH News Daily 2017 - Issue 2 - C-4
ASH News Daily 2017 - Issue 2 - C-5
ASH News Daily 2017 - Issue 2 - C-6
ASH News Daily 2017 - Issue 2 - C-7
ASH News Daily 2017 - Issue 2 - C-8
ASH News Daily 2017 - Issue 2 - C-9
ASH News Daily 2017 - Issue 2 - C-10
ASH News Daily 2017 - Issue 2 - C-11
ASH News Daily 2017 - Issue 2 - C-12
ASH News Daily 2017 - Issue 2 - C-13
ASH News Daily 2017 - Issue 2 - C-14
ASH News Daily 2017 - Issue 2 - C-15
ASH News Daily 2017 - Issue 2 - C-16
ASH News Daily 2017 - Issue 2 - C-17
ASH News Daily 2017 - Issue 2 - C-18
ASH News Daily 2017 - Issue 2 - C-19
ASH News Daily 2017 - Issue 2 - C-20
ASH News Daily 2017 - Issue 2 - C-21
ASH News Daily 2017 - Issue 2 - C-22
ASH News Daily 2017 - Issue 2 - C-23
ASH News Daily 2017 - Issue 2 - C-24
ASH News Daily 2017 - Issue 2 - C-25
ASH News Daily 2017 - Issue 2 - C-26
ASH News Daily 2017 - Issue 2 - C-27
ASH News Daily 2017 - Issue 2 - C-28
ASH News Daily 2017 - Issue 2 - C-29
ASH News Daily 2017 - Issue 2 - C-30
ASH News Daily 2017 - Issue 2 - C-31
ASH News Daily 2017 - Issue 2 - C-32
https://www.nxtbookmedia.com